Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer

ABSTRACT: To assess the efficacy and safety of gemcitabine given by fixed dose rate intravenous infusion in patients with pretreated metastatic colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2021012 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR